Case Study Series - C&EN Global Enterprise (ACS Publications)

Advertisements that appeared within the print issues of Chem. Eng. News have been included in the C&EN Archives to provide a comprehensive representat...
0 downloads 0 Views 333KB Size
Albany Molecular Research, Inc.

t l / f i t y Series SSflSS Cose SStudy

QQ$Q

Metabolism Screening Technologies ;vi Project g o a l : To prioritize leads from several related chemical series, each possessing comparable biological activity. Details: Several series of lead compounds had comparable biological activity. The customer sought to prioritize and develop analogs based upon favorable metabolic characteristics, including half-life. O u t c o m e : AMRI's scientists delivered the following results within two weeks: • Ranked the in vitro metabolic stability of each series and derivatives relative to others. • Identified structural features within the classes consistent with improved metabolic stability, and reported these to the medicinal chemists for further analog design. • Identified the primary human metabolic enzyme isoform involved in the metabolism of the lead series, as well as the identity of the major metabolites formed.

iBlll

21 Corporate Circle, P.O. Box 15098 Albany, New York 12212-5098 Phone:518-464-0279 Fax:518-464-0289 [email protected] www.albmolecular.com

AMRI now offers in vitro metabolic tests to support lead optimization. • Metabolic Stability Assays • Metabolic Profiling Assays • Metabolite Production • CYP450 Isoform Analysis

• Identified the mouse as an appropriate animal model system that most closely represented the human metabolic pattern for this class of compounds.

• CYP450 Inhibition Assays

Call AMRI today to learn how we can help your drug development efforts.

• Identified that selected derivatives of the lead series did not significantly inhibit any of the major human liver cytochrome P450 enzymes. Follow-up: Produced 10 mg of two human metabolites of interest within three weeks for further evaluation.

AMRI'S Fine Chemicals Catalog OCH 3

OH

NH2

9

2HCI ChLO

N

K ^

NHBoc NHo

HO' Both enantiomers available

H,C

CT

T>H

.

N

NH,

BocHN

NH2

NH,

CP Both enantiomers available

Both enantiomers available

Many phenylalanine derivatives

E52

Albany Molecular Research. Inc.®

21 Corporate Circle, P.O. Box 15098 • Albany, New York 12212-5098 Phone:877-388-4675 x5151 • Fax:315-458-9293 • [email protected] • www.albmolecular.com

t r ^ / Jk \ Sa^X < a %-:;/-

•Ol-:-

:j£^

k^0*?"/:^ Jk • ''$te*H